PIONEERING CELL THERAPIES
Live / Registered — Registered (as of 18 Feb 2020)
What this means for you
Registered since 18 Feb 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 87543744
- Registration number
- 5991584
- Mark type
- Stylized text
- Filed
- 26 Jul 2017
- Published for opposition
- 25 Dec 2018
- Registered
- 18 Feb 2020
Goods and services
- Class 042 — Scientific and technological services: Product research and development; Scientific research for medical purposes in the field of cell therapies
Owner
- CellTrans Inc., Chicago, IL, US
- CellTrans Inc., Chicago, IL, US
- CellTrans Inc., Chicago, IL, US
Prosecution history
- 09 Mar 2026 — TEAS SECTION 8 RECEIVED
- 18 Feb 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 18 Feb 2020 — REGISTERED-PRINCIPAL REGISTER
- 14 Jan 2020 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 13 Jan 2020 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 13 Jan 2020 — STATEMENT OF USE PROCESSING COMPLETE
- 30 Dec 2019 — USE AMENDMENT FILED
- 09 Jan 2020 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 30 Dec 2019 — TEAS STATEMENT OF USE RECEIVED
- 30 Jul 2019 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 26 Jul 2019 — SOU EXTENSION 1 GRANTED
- 26 Jul 2019 — SOU EXTENSION 1 FILED
- 26 Jul 2019 — SOU TEAS EXTENSION RECEIVED
- 19 Feb 2019 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 25 Dec 2018 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED